1-5 of 5
M Takeshita
Close
Sort by
Journal Articles

Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease

GS Wood, DL Hardman, R Boni, R Dummer, YH Kim, BR Smoller, M Takeshita, M Kikuchi, G Burg
Journal: Blood
Blood (1996) 88 (5): 1765–1770.
https://doi.org/10.1182/blood.V88.5.1765.1765
Published: 1996
Journal Articles

Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity

M Shiota, S Nakamura, R Ichinohasama, M Abe, T Akagi, M Takeshita, N Mori, J Fujimoto, J Miyauchi, A Mikata
Journal: Blood
Blood (1995) 86 (5): 1954–1960.
https://doi.org/10.1182/blood.V86.5.1954.bloodjournal8651954
Published: 1995
Journal Articles

Expression of adult and fetal natural killer cell markers in sinonasal lymphomas [see comments]

J Suzumiya, M Takeshita, N Kimura, M Kikuchi, T Uchida, S Hisano, Y Eura, M Kozuru, Y Nomura, K Tomita
Journal: Blood
Blood (1994) 83 (8): 2255–2260.
https://doi.org/10.1182/blood.V83.8.2255.2255
Published: 1994
Journal Articles

Analysis of mutant NADH-cytochrome b5 reductase: apparent "type III" methemoglobinemia can be explained as type I with an unstable reductase

T Nagai, K Shirabe, T Yubisui, M Takeshita
Journal: Blood
Blood (1993) 81 (3): 808–814.
https://doi.org/10.1182/blood.V81.3.808.808
Published: 1993
Journal Articles

Abnormal parachloromercuriphenylsulfonate-sensitive cation channel in the erythrocytes of hereditary spherocytosis

T Kitao, K Hattori, M Takeshita
Journal: Blood
Blood (1976) 47 (4): 651–655.
https://doi.org/10.1182/blood.V47.4.651.651
Published: 1976